UK's chief regulator speaks out on communication agenda
This article was originally published in Clinica
Executive Summary
How is the UK's Medicines and Healthcare products Regulatory Agency (MHRA) going to improve its communications with stakeholders, and particularly the medical devices industry, after criticism that it has not been accessible enough since the medicines and medical devices authorities merged in April 2003 and that it has lost its dedicated figurehead for devices? Amanda Maxwell interviewed MHRA chief executive Professor Kent Woods to find out